Renato M. Guzman
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of access to treatment on patient-reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin-American countries: A prospective observational study.
Journal: Health science reports
Published: August 01, 2022
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries.
Journal: Reumatologia clinica
Published: July 19, 2022
Work productivity in rheumatoid arthritis patients from two Latin American countries treated with tofacitinib or biological DMARDs.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 07, 2022
Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.
Journal: Journal of medical virology
Published: May 13, 2020
Biology of anti-TNF agents in immune-mediated inflammatory diseases: therapeutic implications.
Journal: Immunotherapy
Published: October 15, 2016
Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region.
Journal: The open rheumatology journal
Published: April 01, 2015
Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: December 21, 2013
Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies.
Journal: Joint bone spine
Published: November 04, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026